Gilead Sciences filed a trademark application on March 26 to protect the design of a drug bottle that would be used for coronavirus treatment. The filing suggests that the pharmaceutical company could be anticipating the release of a product soon.
Josh Gerben was quoted Axios discussing why a company would trademark its packaging:
“The reason you make this trademark is because you think you’re going to get a product out there soon.”
“This is part of your brand protection.”
Gilead has filed a trademark application to protect the design of its coronavirus drug bottle.
The filing, made on March 26th with the USPTO, indicates that Gilead has a "bona fide intent to use" this bottle design for a coronavirus treatment.
— Josh Gerben (@JoshGerben) April 14, 2020
Source: Herman, Bob. “Gilead has filed for a trademark on the bottle for a coronavirus drug.” Axios.com. 15 April 2020.